Imaging agents for diagnosis of Parkinson's disease
    3.
    发明授权
    Imaging agents for diagnosis of Parkinson's disease 失效
    用于诊断帕金森病的成像剂

    公开(公告)号:US06677454B2

    公开(公告)日:2004-01-13

    申请号:US10352764

    申请日:2003-01-28

    IPC分类号: C07D21160

    CPC分类号: A61K51/0497 A61K51/0478

    摘要: Generally, the present invention is directed to central nervous system dopamine transporter-imaging agents and methods of use thereof. In certain embodiments, the present invention relates to radiolabeled piperidine derivatives for use as imaging agents in the diagnosis of Parkinson's disease. Another aspect of the present invention relates to piperidine monoamine transporter ligands, comprising a functional group capable of chelating a radionuclide, e.g., technetium, and methods of use thereof.

    摘要翻译: 通常,本发明涉及中枢神经系统多巴胺转运体显像剂及其使用方法。 在某些实施方案中,本发明涉及放射性标记的哌啶衍生物,用作帕金森病诊断中的显像剂。 本发明的另一方面涉及包含能够螯合放射性核素(例如锝)的官能团的哌啶单胺转运体配体及其使用方法。

    Process for preparation of benzylpiperidine compounds
    5.
    发明授权
    Process for preparation of benzylpiperidine compounds 失效
    苄基哌啶化合物的制备方法

    公开(公告)号:US06833457B1

    公开(公告)日:2004-12-21

    申请号:US10466494

    申请日:2003-07-17

    IPC分类号: C07D21160

    摘要: According to the process as shown in the following scheme having a step for reacting Compound (I) with Compound (II) to produce Compound (III), benzylpiperidine compounds useful as synthesis starting materials of pharmaceutical agents, agricultural chemicals and the like can be produced conveniently by a short step: wherein R1 is a hydrogen atom or an amino-protecting group, R2 is a hydrogen atom, a hydrocarbon group optionally having substituents, an alkoxy group optionally having substituents or a heterocyclic group optionally having substituents, and R3 is a lower alkyl group.

    摘要翻译: 根据具有使化合物(I)与化合物(II)反应生成化合物(III)的步骤的方法所示的方法,可以制备用作药剂,农药等的合成原料的苄基哌啶化合物 方便地通过短步骤:其中R 1是氢原子或氨基保护基,R 2是氢原子,任选具有取代基的烃基,任选具有取代基的烷氧基或任选具有取代基的杂环基 取代基,R 3为低级烷基。